Organization
University of Campania Luigi Vanvitelli
5 clinical trials
Clinical trial
CAPRI 2 GOIM Study: Investigate the Efficacy and Safety of a Bio- Marker-driven Cetuximab-based Treatment Regimen Over 3 Treatment Lines in mCRC Patients With RAS/BRAF wt Tumors at Start of First LineStatus: Active (not recruiting), Estimated PCD: 2025-08-15
Clinical trial
Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO TrialStatus: Completed, Estimated PCD: 2022-05-31
Clinical trial
CAVE-2 (Cetuximab-AVElumab) mCRC: A Phase II Randomized Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy in Pre-treated RAS/BRAF Wild Type Metastatic Colorectal Cancer Patients.Status: Recruiting, Estimated PCD: 2025-07-01
Clinical trial
Effects of Gliflozins on Markers of Cardiovascular Risk in Type 2 Diabetes (GIOIA): a Multicenter Pragmatic Prospective Cohort StudyStatus: Completed, Estimated PCD: 2023-12-31
Clinical trial
A Phase II Trial Evaluating the Activity of caBozantinib in Pre-treated pAtients With Metastatic COlorectal Cancer (mCRC). ABACO Trial.Status: Active (not recruiting), Estimated PCD: 2024-12-31